Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-16

FDA Approved: DIFLUNISAL — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved a generic diflunisal product (DIFLUNISAL) under ANDA 203547 for Zydus Pharmaceuticals USA Inc. It is indicated for relief of mild to moderate pain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFLUNISAL (Diflunisal)

Snippet

ORIG AP for DIFLUNISAL (DIFLUNISAL)